“Post-translational Modifications and Protease-cleaved Fragments of Tau Protein in Alzheimer’s Disease and Tauopathies: Diagnostic and Therapeutic Implications”

https://pubmed.ncbi.nlm.nih.gov/38114762

The abstract provides an overview of how post-translational modifications and protease-cleaved fragments of tau protein contribute to the pathogenesis of Alzheimer’s disease and other tauopathies, highlighting the potential of further exploration for diagnostic and therapeutic purposes.